The hematology-oncology sector continues to witness transformative changes, with mantle cell lymphoma representing one of the most dynamic and rapidly evolving therapeutic areas. This aggressive B-cell malignancy, once considered virtually incurable, now offers patients unprecedented treatment options and improved survival prospects. Market Foundation and Economic Impact The Mantle Cell Lymphoma Market Size reflects the growing… Read.